Multivariable model for factors affecting PFS in patients with aggressive NHL who achieved CR
| Variable . | HR . | 95% CI . | P . |
|---|---|---|---|
| LDH, pre-lymphodepletion* | 1.26 | 0.67-2.38 | .47 |
| MCP-1, day 0 (before CAR T-cell infusion)† | 1.13 | 0.21-6.26 | .89 |
| IL-7, peak‡ | 0.70 | 0.49-1.00 | .05 |
| Variable . | HR . | 95% CI . | P . |
|---|---|---|---|
| LDH, pre-lymphodepletion* | 1.26 | 0.67-2.38 | .47 |
| MCP-1, day 0 (before CAR T-cell infusion)† | 1.13 | 0.21-6.26 | .89 |
| IL-7, peak‡ | 0.70 | 0.49-1.00 | .05 |
Cox regression model was performed to assess the association between PFS and the 3 variables of interest, in which log10 values were used to transform data as appropriate, with 0.001 substituting for values of 0.
Per 100 U/L increment.
Per log10 pg/mL serum concentration increment.
Per 5 pg/mL serum concentration increment.